Global Prostate Cancer Therapeutics Drugs Market Growth 2022-2028

1.1 Market Introduction

1.2 Years Considered

1.3 Research Objectives

1.4 Market Research Methodology

1.5 Research Process and Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global Prostate Cancer Therapeutics Drugs Annual Sales 2017-2028

2.1.2 World Current & Future Analysis for Prostate Cancer Therapeutics Drugs by Geographic Region, 2017, 2022 & 2028

2.1.3 World Current & Future Analysis for Prostate Cancer Therapeutics Drugs by Country/Region, 2017, 2022 & 2028

2.2 Prostate Cancer Therapeutics Drugs Segment by Type

2.2.1 Hormone Therapy

2.2.2 Chemotherapy

2.2.3 Biologic Therapy

2.2.4 Targeted Therapy

2.2.5 Other

2.3 Prostate Cancer Therapeutics Drugs Sales by Type

2.3.1 Global Prostate Cancer Therapeutics Drugs Sales Market Share by Type (2017-2022)

2.3.2 Global Prostate Cancer Therapeutics Drugs Revenue and Market Share by Type (2017-2022)

2.3.3 Global Prostate Cancer Therapeutics Drugs Sale Price by Type (2017-2022)

2.4 Prostate Cancer Therapeutics Drugs Segment by Sale Channel

2.4.1 Hospital Pharmacy

2.4.2 Retail Pharmacy

2.4.3 Online Sales

2.4.4 Other

2.5 Prostate Cancer Therapeutics Drugs Sales by Sale Channel

2.5.1 Global Prostate Cancer Therapeutics Drugs Sale Market Share by Sale Channel (2017-2022)

2.5.2 Global Prostate Cancer Therapeutics Drugs Revenue and Market Share by Sale Channel (2017-2022)

2.5.3 Global Prostate Cancer Therapeutics Drugs Sale Price by Sale Channel (2017-2022)

3 Global Prostate Cancer Therapeutics Drugs by Company

3.1 Global Prostate Cancer Therapeutics Drugs Breakdown Data by Company

3.1.1 Global Prostate Cancer Therapeutics Drugs Annual Sales by Company (2020-2022)

3.1.2 Global Prostate Cancer Therapeutics Drugs Sales Market Share by Company (2020-2022)

3.2 Global Prostate Cancer Therapeutics Drugs Annual Revenue by Company (2020-2022)

3.2.1 Global Prostate Cancer Therapeutics Drugs Revenue by Company (2020-2022)

3.2.2 Global Prostate Cancer Therapeutics Drugs Revenue Market Share by Company (2020-2022)

3.3 Global Prostate Cancer Therapeutics Drugs Sale Price by Company

3.4 Key Manufacturers Prostate Cancer Therapeutics Drugs Producing Area Distribution, Sales Area, Product Type

3.4.1 Key Manufacturers Prostate Cancer Therapeutics Drugs Product Location Distribution

3.4.2 Players Prostate Cancer Therapeutics Drugs Products Offered

3.5 Market Concentration Rate Analysis

3.5.1 Competition Landscape Analysis

3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

3.6 New Products and Potential Entrants

3.7 Mergers & Acquisitions, Expansion

4 World Historic Review for Prostate Cancer Therapeutics Drugs by Geographic Region

4.1 World Historic Prostate Cancer Therapeutics Drugs Market Size by Geographic Region (2017-2022)

4.1.1 Global Prostate Cancer Therapeutics Drugs Annual Sales by Geographic Region (2017-2022)

4.1.2 Global Prostate Cancer Therapeutics Drugs Annual Revenue by Geographic Region

4.2 World Historic Prostate Cancer Therapeutics Drugs Market Size by Country/Region (2017-2022)

4.2.1 Global Prostate Cancer Therapeutics Drugs Annual Sales by Country/Region (2017-2022)

4.2.2 Global Prostate Cancer Therapeutics Drugs Annual Revenue by Country/Region

4.3 Americas Prostate Cancer Therapeutics Drugs Sales Growth

4.4 APAC Prostate Cancer Therapeutics Drugs Sales Growth

4.5 Europe Prostate Cancer Therapeutics Drugs Sales Growth

4.6 Middle East & Africa Prostate Cancer Therapeutics Drugs Sales Growth

5 Americas

5.1 Americas Prostate Cancer Therapeutics Drugs Sales by Country

5.1.1 Americas Prostate Cancer Therapeutics Drugs Sales by Country (2017-2022)

5.1.2 Americas Prostate Cancer Therapeutics Drugs Revenue by Country (2017-2022)

5.2 Americas Prostate Cancer Therapeutics Drugs Sales by Type

5.3 Americas Prostate Cancer Therapeutics Drugs Sales by Sale Channel

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

6 APAC

6.1 APAC Prostate Cancer Therapeutics Drugs Sales by Region

6.1.1 APAC Prostate Cancer Therapeutics Drugs Sales by Region (2017-2022)

6.1.2 APAC Prostate Cancer Therapeutics Drugs Revenue by Region (2017-2022)

6.2 APAC Prostate Cancer Therapeutics Drugs Sales by Type

6.3 APAC Prostate Cancer Therapeutics Drugs Sales by Sale Channel

6.4 China

6.5 Japan

6.6 South Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

6.10 China Taiwan

7 Europe

7.1 Europe Prostate Cancer Therapeutics Drugs by Country

7.1.1 Europe Prostate Cancer Therapeutics Drugs Sales by Country (2017-2022)

7.1.2 Europe Prostate Cancer Therapeutics Drugs Revenue by Country (2017-2022)

7.2 Europe Prostate Cancer Therapeutics Drugs Sales by Type

7.3 Europe Prostate Cancer Therapeutics Drugs Sales by Sale Channel

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

8 Middle East & Africa

8.1 Middle East & Africa Prostate Cancer Therapeutics Drugs by Country

8.1.1 Middle East & Africa Prostate Cancer Therapeutics Drugs Sales by Country (2017-2022)

8.1.2 Middle East & Africa Prostate Cancer Therapeutics Drugs Revenue by Country (2017-2022)

8.2 Middle East & Africa Prostate Cancer Therapeutics Drugs Sales by Type

8.3 Middle East & Africa Prostate Cancer Therapeutics Drugs Sales by Sale Channel

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Countries

9 Market Drivers, Challenges and Trends

9.1 Market Drivers & Growth Opportunities

9.2 Market Challenges & Risks

9.3 Industry Trends

10 Manufacturing Cost Structure Analysis

10.1 Raw Material and Suppliers

10.2 Manufacturing Cost Structure Analysis of Prostate Cancer Therapeutics Drugs

10.3 Manufacturing Process Analysis of Prostate Cancer Therapeutics Drugs

10.4 Industry Chain Structure of Prostate Cancer Therapeutics Drugs

11 Marketing, Distributors and Customer

11.1 Sales Channel

11.1.1 Direct Channels

11.1.2 Indirect Channels

11.2 Prostate Cancer Therapeutics Drugs Distributors

11.3 Prostate Cancer Therapeutics Drugs Customer

12 World Forecast Review for Prostate Cancer Therapeutics Drugs by Geographic Region

12.1 Global Prostate Cancer Therapeutics Drugs Market Size Forecast by Region

12.1.1 Global Prostate Cancer Therapeutics Drugs Forecast by Region (2023-2028)

12.1.2 Global Prostate Cancer Therapeutics Drugs Annual Revenue Forecast by Region (2023-2028)

12.2 Americas Forecast by Country

12.3 APAC Forecast by Region

12.4 Europe Forecast by Country

12.5 Middle East & Africa Forecast by Country

12.6 Global Prostate Cancer Therapeutics Drugs Forecast by Type

12.7 Global Prostate Cancer Therapeutics Drugs Forecast by Sale Channel

13 Key Players Analysis

13.1 Johnson & Johnson

13.1.1 Johnson & Johnson Company Information

13.1.2 Johnson & Johnson Prostate Cancer Therapeutics Drugs Product Offered

13.1.3 Johnson & Johnson Prostate Cancer Therapeutics Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.1.4 Johnson & Johnson Main Business Overview

13.1.5 Johnson & Johnson Latest Developments

13.2 Pfizer, Inc

13.2.1 Pfizer, Inc Company Information

13.2.2 Pfizer, Inc Prostate Cancer Therapeutics Drugs Product Offered

13.2.3 Pfizer, Inc Prostate Cancer Therapeutics Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.2.4 Pfizer, Inc Main Business Overview

13.2.5 Pfizer, Inc Latest Developments

13.3 AstraZeneca

13.3.1 AstraZeneca Company Information

13.3.2 AstraZeneca Prostate Cancer Therapeutics Drugs Product Offered

13.3.3 AstraZeneca Prostate Cancer Therapeutics Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.3.4 AstraZeneca Main Business Overview

13.3.5 AstraZeneca Latest Developments

13.4 Amgen, Inc

13.4.1 Amgen, Inc Company Information

13.4.2 Amgen, Inc Prostate Cancer Therapeutics Drugs Product Offered

13.4.3 Amgen, Inc Prostate Cancer Therapeutics Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.4.4 Amgen, Inc Main Business Overview

13.4.5 Amgen, Inc Latest Developments

13.5 AbbVie, Inc

13.5.1 AbbVie, Inc Company Information

13.5.2 AbbVie, Inc Prostate Cancer Therapeutics Drugs Product Offered

13.5.3 AbbVie, Inc Prostate Cancer Therapeutics Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.5.4 AbbVie, Inc Main Business Overview

13.5.5 AbbVie, Inc Latest Developments

13.6 Bayer AG

13.6.1 Bayer AG Company Information

13.6.2 Bayer AG Prostate Cancer Therapeutics Drugs Product Offered

13.6.3 Bayer AG Prostate Cancer Therapeutics Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.6.4 Bayer AG Main Business Overview

13.6.5 Bayer AG Latest Developments

13.7 Ipsen Group

13.7.1 Ipsen Group Company Information

13.7.2 Ipsen Group Prostate Cancer Therapeutics Drugs Product Offered

13.7.3 Ipsen Group Prostate Cancer Therapeutics Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.7.4 Ipsen Group Main Business Overview

13.7.5 Ipsen Group Latest Developments

13.8 Sanofi

13.8.1 Sanofi Company Information

13.8.2 Sanofi Prostate Cancer Therapeutics Drugs Product Offered

13.8.3 Sanofi Prostate Cancer Therapeutics Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.8.4 Sanofi Main Business Overview

13.8.5 Sanofi Latest Developments

13.9 Endo Pharmaceuticals

13.9.1 Endo Pharmaceuticals Company Information

13.9.2 Endo Pharmaceuticals Prostate Cancer Therapeutics Drugs Product Offered

13.9.3 Endo Pharmaceuticals Prostate Cancer Therapeutics Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.9.4 Endo Pharmaceuticals Main Business Overview

13.9.5 Endo Pharmaceuticals Latest Developments

13.10 Dendreon Corporation

13.10.1 Dendreon Corporation Company Information

13.10.2 Dendreon Corporation Prostate Cancer Therapeutics Drugs Product Offered

13.10.3 Dendreon Corporation Prostate Cancer Therapeutics Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.10.4 Dendreon Corporation Main Business Overview

13.10.5 Dendreon Corporation Latest Developments

14 Research Findings and Conclusion

Table 1. Prostate Cancer Therapeutics Drugs Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)

Table 2. Prostate Cancer Therapeutics Drugs Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)

Table 3. Major Players of Hormone Therapy

Table 4. Major Players of Chemotherapy

Table 5. Major Players of Biologic Therapy

Table 6. Major Players of Targeted Therapy

Table 7. Major Players of Other

Table 8. Global Prostate Cancer Therapeutics Drugs Sales by Type (2017-2022) & (K Pcs)

Table 9. Global Prostate Cancer Therapeutics Drugs Sales Market Share by Type (2017-2022)

Table 10. Global Prostate Cancer Therapeutics Drugs Revenue by Type (2017-2022) & ($ million)

Table 11. Global Prostate Cancer Therapeutics Drugs Revenue Market Share by Type (2017-2022)

Table 12. Global Prostate Cancer Therapeutics Drugs Sale Price by Type (2017-2022) & (USD/Pcs)

Table 13. Global Prostate Cancer Therapeutics Drugs Sales by Sale Channel (2017-2022) & (K Pcs)

Table 14. Global Prostate Cancer Therapeutics Drugs Sales Market Share by Sale Channel (2017-2022)

Table 15. Global Prostate Cancer Therapeutics Drugs Revenue by Sale Channel (2017-2022)

Table 16. Global Prostate Cancer Therapeutics Drugs Revenue Market Share by Sale Channel (2017-2022)

Table 17. Global Prostate Cancer Therapeutics Drugs Sale Price by Sale Channel (2017-2022) & (USD/Pcs)

Table 18. Global Prostate Cancer Therapeutics Drugs Sales by Company (2020-2022) & (K Pcs)

Table 19. Global Prostate Cancer Therapeutics Drugs Sales Market Share by Company (2020-2022)

Table 20. Global Prostate Cancer Therapeutics Drugs Revenue by Company (2020-2022) ($ Millions)

Table 21. Global Prostate Cancer Therapeutics Drugs Revenue Market Share by Company (2020-2022)

Table 22. Global Prostate Cancer Therapeutics Drugs Sale Price by Company (2020-2022) & (USD/Pcs)

Table 23. Key Manufacturers Prostate Cancer Therapeutics Drugs Producing Area Distribution and Sales Area

Table 24. Players Prostate Cancer Therapeutics Drugs Products Offered

Table 25. Prostate Cancer Therapeutics Drugs Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

Table 26. New Products and Potential Entrants

Table 27. Mergers & Acquisitions, Expansion

Table 28. Global Prostate Cancer Therapeutics Drugs Sales by Geographic Region (2017-2022) & (K Pcs)

Table 29. Global Prostate Cancer Therapeutics Drugs Sales Market Share Geographic Region (2017-2022)

Table 30. Global Prostate Cancer Therapeutics Drugs Revenue by Geographic Region (2017-2022) & ($ millions)

Table 31. Global Prostate Cancer Therapeutics Drugs Revenue Market Share by Geographic Region (2017-2022)

Table 32. Global Prostate Cancer Therapeutics Drugs Sales by Country/Region (2017-2022) & (K Pcs)

Table 33. Global Prostate Cancer Therapeutics Drugs Sales Market Share by Country/Region (2017-2022)

Table 34. Global Prostate Cancer Therapeutics Drugs Revenue by Country/Region (2017-2022) & ($ millions)

Table 35. Global Prostate Cancer Therapeutics Drugs Revenue Market Share by Country/Region (2017-2022)

Table 36. Americas Prostate Cancer Therapeutics Drugs Sales by Country (2017-2022) & (K Pcs)

Table 37. Americas Prostate Cancer Therapeutics Drugs Sales Market Share by Country (2017-2022)

Table 38. Americas Prostate Cancer Therapeutics Drugs Revenue by Country (2017-2022) & ($ Millions)

Table 39. Americas Prostate Cancer Therapeutics Drugs Revenue Market Share by Country (2017-2022)

Table 40. Americas Prostate Cancer Therapeutics Drugs Sales by Type (2017-2022) & (K Pcs)

Table 41. Americas Prostate Cancer Therapeutics Drugs Sales Market Share by Type (2017-2022)

Table 42. Americas Prostate Cancer Therapeutics Drugs Sales by Sale Channel (2017-2022) & (K Pcs)

Table 43. Americas Prostate Cancer Therapeutics Drugs Sales Market Share by Sale Channel (2017-2022)

Table 44. APAC Prostate Cancer Therapeutics Drugs Sales by Region (2017-2022) & (K Pcs)

Table 45. APAC Prostate Cancer Therapeutics Drugs Sales Market Share by Region (2017-2022)

Table 46. APAC Prostate Cancer Therapeutics Drugs Revenue by Region (2017-2022) & ($ Millions)

Table 47. APAC Prostate Cancer Therapeutics Drugs Revenue Market Share by Region (2017-2022)

Table 48. APAC Prostate Cancer Therapeutics Drugs Sales by Type (2017-2022) & (K Pcs)

Table 49. APAC Prostate Cancer Therapeutics Drugs Sales Market Share by Type (2017-2022)

Table 50. APAC Prostate Cancer Therapeutics Drugs Sales by Sale Channel (2017-2022) & (K Pcs)

Table 51. APAC Prostate Cancer Therapeutics Drugs Sales Market Share by Sale Channel (2017-2022)

Table 52. Europe Prostate Cancer Therapeutics Drugs Sales by Country (2017-2022) & (K Pcs)

Table 53. Europe Prostate Cancer Therapeutics Drugs Sales Market Share by Country (2017-2022)

Table 54. Europe Prostate Cancer Therapeutics Drugs Revenue by Country (2017-2022) & ($ Millions)

Table 55. Europe Prostate Cancer Therapeutics Drugs Revenue Market Share by Country (2017-2022)

Table 56. Europe Prostate Cancer Therapeutics Drugs Sales by Type (2017-2022) & (K Pcs)

Table 57. Europe Prostate Cancer Therapeutics Drugs Sales Market Share by Type (2017-2022)

Table 58. Europe Prostate Cancer Therapeutics Drugs Sales by Sale Channel (2017-2022) & (K Pcs)

Table 59. Europe Prostate Cancer Therapeutics Drugs Sales Market Share by Sale Channel (2017-2022)

Table 60. Middle East & Africa Prostate Cancer Therapeutics Drugs Sales by Country (2017-2022) & (K Pcs)

Table 61. Middle East & Africa Prostate Cancer Therapeutics Drugs Sales Market Share by Country (2017-2022)

Table 62. Middle East & Africa Prostate Cancer Therapeutics Drugs Revenue by Country (2017-2022) & ($ Millions)

Table 63. Middle East & Africa Prostate Cancer Therapeutics Drugs Revenue Market Share by Country (2017-2022)

Table 64. Middle East & Africa Prostate Cancer Therapeutics Drugs Sales by Type (2017-2022) & (K Pcs)

Table 65. Middle East & Africa Prostate Cancer Therapeutics Drugs Sales Market Share by Type (2017-2022)

Table 66. Middle East & Africa Prostate Cancer Therapeutics Drugs Sales by Sale Channel (2017-2022) & (K Pcs)

Table 67. Middle East & Africa Prostate Cancer Therapeutics Drugs Sales Market Share by Sale Channel (2017-2022)

Table 68. Key Market Drivers & Growth Opportunities of Prostate Cancer Therapeutics Drugs

Table 69. Key Market Challenges & Risks of Prostate Cancer Therapeutics Drugs

Table 70. Key Industry Trends of Prostate Cancer Therapeutics Drugs

Table 71. Prostate Cancer Therapeutics Drugs Raw Material

Table 72. Key Suppliers of Raw Materials

Table 73. Prostate Cancer Therapeutics Drugs Distributors List

Table 74. Prostate Cancer Therapeutics Drugs Customer List

Table 75. Global Prostate Cancer Therapeutics Drugs Sales Forecast by Region (2023-2028) & (K Pcs)

Table 76. Global Prostate Cancer Therapeutics Drugs Sales Market Forecast by Region

Table 77. Global Prostate Cancer Therapeutics Drugs Revenue Forecast by Region (2023-2028) & ($ millions)

Table 78. Global Prostate Cancer Therapeutics Drugs Revenue Market Share Forecast by Region (2023-2028)

Table 79. Americas Prostate Cancer Therapeutics Drugs Sales Forecast by Country (2023-2028) & (K Pcs)

Table 80. Americas Prostate Cancer Therapeutics Drugs Revenue Forecast by Country (2023-2028) & ($ millions)

Table 81. APAC Prostate Cancer Therapeutics Drugs Sales Forecast by Region (2023-2028) & (K Pcs)

Table 82. APAC Prostate Cancer Therapeutics Drugs Revenue Forecast by Region (2023-2028) & ($ millions)

Table 83. Europe Prostate Cancer Therapeutics Drugs Sales Forecast by Country (2023-2028) & (K Pcs)

Table 84. Europe Prostate Cancer Therapeutics Drugs Revenue Forecast by Country (2023-2028) & ($ millions)

Table 85. Middle East & Africa Prostate Cancer Therapeutics Drugs Sales Forecast by Country (2023-2028) & (K Pcs)

Table 86. Middle East & Africa Prostate Cancer Therapeutics Drugs Revenue Forecast by Country (2023-2028) & ($ millions)

Table 87. Global Prostate Cancer Therapeutics Drugs Sales Forecast by Type (2023-2028) & (K Pcs)

Table 88. Global Prostate Cancer Therapeutics Drugs Sales Market Share Forecast by Type (2023-2028)

Table 89. Global Prostate Cancer Therapeutics Drugs Revenue Forecast by Type (2023-2028) & ($ Millions)

Table 90. Global Prostate Cancer Therapeutics Drugs Revenue Market Share Forecast by Type (2023-2028)

Table 91. Global Prostate Cancer Therapeutics Drugs Sales Forecast by Sale Channel (2023-2028) & (K Pcs)

Table 92. Global Prostate Cancer Therapeutics Drugs Sales Market Share Forecast by Sale Channel (2023-2028)

Table 93. Global Prostate Cancer Therapeutics Drugs Revenue Forecast by Sale Channel (2023-2028) & ($ Millions)

Table 94. Global Prostate Cancer Therapeutics Drugs Revenue Market Share Forecast by Sale Channel (2023-2028)

Table 95. Johnson & Johnson Basic Information, Prostate Cancer Therapeutics Drugs Manufacturing Base, Sales Area and Its Competitors

Table 96. Johnson & Johnson Prostate Cancer Therapeutics Drugs Product Offered

Table 97. Johnson & Johnson Prostate Cancer Therapeutics Drugs Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 98. Johnson & Johnson Main Business

Table 99. Johnson & Johnson Latest Developments

Table 100. Pfizer, Inc Basic Information, Prostate Cancer Therapeutics Drugs Manufacturing Base, Sales Area and Its Competitors

Table 101. Pfizer, Inc Prostate Cancer Therapeutics Drugs Product Offered

Table 102. Pfizer, Inc Prostate Cancer Therapeutics Drugs Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 103. Pfizer, Inc Main Business

Table 104. Pfizer, Inc Latest Developments

Table 105. AstraZeneca Basic Information, Prostate Cancer Therapeutics Drugs Manufacturing Base, Sales Area and Its Competitors

Table 106. AstraZeneca Prostate Cancer Therapeutics Drugs Product Offered

Table 107. AstraZeneca Prostate Cancer Therapeutics Drugs Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 108. AstraZeneca Main Business

Table 109. AstraZeneca Latest Developments

Table 110. Amgen, Inc Basic Information, Prostate Cancer Therapeutics Drugs Manufacturing Base, Sales Area and Its Competitors

Table 111. Amgen, Inc Prostate Cancer Therapeutics Drugs Product Offered

Table 112. Amgen, Inc Prostate Cancer Therapeutics Drugs Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 113. Amgen, Inc Main Business

Table 114. Amgen, Inc Latest Developments

Table 115. AbbVie, Inc Basic Information, Prostate Cancer Therapeutics Drugs Manufacturing Base, Sales Area and Its Competitors

Table 116. AbbVie, Inc Prostate Cancer Therapeutics Drugs Product Offered

Table 117. AbbVie, Inc Prostate Cancer Therapeutics Drugs Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 118. AbbVie, Inc Main Business

Table 119. AbbVie, Inc Latest Developments

Table 120. Bayer AG Basic Information, Prostate Cancer Therapeutics Drugs Manufacturing Base, Sales Area and Its Competitors

Table 121. Bayer AG Prostate Cancer Therapeutics Drugs Product Offered

Table 122. Bayer AG Prostate Cancer Therapeutics Drugs Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 123. Bayer AG Main Business

Table 124. Bayer AG Latest Developments

Table 125. Ipsen Group Basic Information, Prostate Cancer Therapeutics Drugs Manufacturing Base, Sales Area and Its Competitors

Table 126. Ipsen Group Prostate Cancer Therapeutics Drugs Product Offered

Table 127. Ipsen Group Prostate Cancer Therapeutics Drugs Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 128. Ipsen Group Main Business

Table 129. Ipsen Group Latest Developments

Table 130. Sanofi Basic Information, Prostate Cancer Therapeutics Drugs Manufacturing Base, Sales Area and Its Competitors

Table 131. Sanofi Prostate Cancer Therapeutics Drugs Product Offered

Table 132. Sanofi Prostate Cancer Therapeutics Drugs Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 133. Sanofi Main Business

Table 134. Sanofi Latest Developments

Table 135. Endo Pharmaceuticals Basic Information, Prostate Cancer Therapeutics Drugs Manufacturing Base, Sales Area and Its Competitors

Table 136. Endo Pharmaceuticals Prostate Cancer Therapeutics Drugs Product Offered

Table 137. Endo Pharmaceuticals Prostate Cancer Therapeutics Drugs Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 138. Endo Pharmaceuticals Main Business

Table 139. Endo Pharmaceuticals Latest Developments

Table 140. Dendreon Corporation Basic Information, Prostate Cancer Therapeutics Drugs Manufacturing Base, Sales Area and Its Competitors

Table 141. Dendreon Corporation Prostate Cancer Therapeutics Drugs Product Offered

Table 142. Dendreon Corporation Prostate Cancer Therapeutics Drugs Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 143. Dendreon Corporation Main Business

Table 144. Dendreon Corporation Latest Developments

List of Figures

Figure 1. Picture of Prostate Cancer Therapeutics Drugs

Figure 2. Prostate Cancer Therapeutics Drugs Report Years Considered

Figure 3. Research Objectives

Figure 4. Research Methodology

Figure 5. Research Process and Data Source

Figure 6. Global Prostate Cancer Therapeutics Drugs Sales Growth Rate 2017-2028 (K Pcs)

Figure 7. Global Prostate Cancer Therapeutics Drugs Revenue Growth Rate 2017-2028 ($ Millions)

Figure 8. Prostate Cancer Therapeutics Drugs Sales by Region (2021 & 2028) & ($ millions)

Figure 9. Product Picture of Hormone Therapy

Figure 10. Product Picture of Chemotherapy

Figure 11. Product Picture of Biologic Therapy

Figure 12. Product Picture of Targeted Therapy

Figure 13. Product Picture of Other

Figure 14. Global Prostate Cancer Therapeutics Drugs Sales Market Share by Type in 2021

Figure 15. Global Prostate Cancer Therapeutics Drugs Revenue Market Share by Type (2017-2022)

Figure 16. Prostate Cancer Therapeutics Drugs Consumed in Hospital Pharmacy

Figure 17. Global Prostate Cancer Therapeutics Drugs Market: Hospital Pharmacy (2017-2022) & (K Pcs)

Figure 18. Prostate Cancer Therapeutics Drugs Consumed in Retail Pharmacy

Figure 19. Global Prostate Cancer Therapeutics Drugs Market: Retail Pharmacy (2017-2022) & (K Pcs)

Figure 20. Prostate Cancer Therapeutics Drugs Consumed in Online Sales

Figure 21. Global Prostate Cancer Therapeutics Drugs Market: Online Sales (2017-2022) & (K Pcs)

Figure 22. Prostate Cancer Therapeutics Drugs Consumed in Other

Figure 23. Global Prostate Cancer Therapeutics Drugs Market: Other (2017-2022) & (K Pcs)

Figure 24. Global Prostate Cancer Therapeutics Drugs Sales Market Share by Sale Channel (2017-2022)

Figure 25. Global Prostate Cancer Therapeutics Drugs Revenue Market Share by Sale Channel in 2021

Figure 26. Prostate Cancer Therapeutics Drugs Revenue Market by Company in 2021 ($ Million)

Figure 27. Global Prostate Cancer Therapeutics Drugs Revenue Market Share by Company in 2021

Figure 28. Global Prostate Cancer Therapeutics Drugs Sales Market Share by Geographic Region (2017-2022)

Figure 29. Global Prostate Cancer Therapeutics Drugs Revenue Market Share by Geographic Region in 2021

Figure 30. Global Prostate Cancer Therapeutics Drugs Sales Market Share by Region (2017-2022)

Figure 31. Global Prostate Cancer Therapeutics Drugs Revenue Market Share by Country/Region in 2021

Figure 32. Americas Prostate Cancer Therapeutics Drugs Sales 2017-2022 (K Pcs)

Figure 33. Americas Prostate Cancer Therapeutics Drugs Revenue 2017-2022 ($ Millions)

Figure 34. APAC Prostate Cancer Therapeutics Drugs Sales 2017-2022 (K Pcs)

Figure 35. APAC Prostate Cancer Therapeutics Drugs Revenue 2017-2022 ($ Millions)

Figure 36. Europe Prostate Cancer Therapeutics Drugs Sales 2017-2022 (K Pcs)

Figure 37. Europe Prostate Cancer Therapeutics Drugs Revenue 2017-2022 ($ Millions)

Figure 38. Middle East & Africa Prostate Cancer Therapeutics Drugs Sales 2017-2022 (K Pcs)

Figure 39. Middle East & Africa Prostate Cancer Therapeutics Drugs Revenue 2017-2022 ($ Millions)

Figure 40. Americas Prostate Cancer Therapeutics Drugs Sales Market Share by Country in 2021

Figure 41. Americas Prostate Cancer Therapeutics Drugs Revenue Market Share by Country in 2021

Figure 42. United States Prostate Cancer Therapeutics Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 43. Canada Prostate Cancer Therapeutics Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 44. Mexico Prostate Cancer Therapeutics Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 45. Brazil Prostate Cancer Therapeutics Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 46. APAC Prostate Cancer Therapeutics Drugs Sales Market Share by Region in 2021

Figure 47. APAC Prostate Cancer Therapeutics Drugs Revenue Market Share by Regions in 2021

Figure 48. China Prostate Cancer Therapeutics Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 49. Japan Prostate Cancer Therapeutics Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 50. South Korea Prostate Cancer Therapeutics Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 51. Southeast Asia Prostate Cancer Therapeutics Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 52. India Prostate Cancer Therapeutics Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 53. Australia Prostate Cancer Therapeutics Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 54. Europe Prostate Cancer Therapeutics Drugs Sales Market Share by Country in 2021

Figure 55. Europe Prostate Cancer Therapeutics Drugs Revenue Market Share by Country in 2021

Figure 56. Germany Prostate Cancer Therapeutics Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 57. France Prostate Cancer Therapeutics Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 58. UK Prostate Cancer Therapeutics Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 59. Italy Prostate Cancer Therapeutics Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 60. Russia Prostate Cancer Therapeutics Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 61. Middle East & Africa Prostate Cancer Therapeutics Drugs Sales Market Share by Country in 2021

Figure 62. Middle East & Africa Prostate Cancer Therapeutics Drugs Revenue Market Share by Country in 2021

Figure 63. Egypt Prostate Cancer Therapeutics Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 64. South Africa Prostate Cancer Therapeutics Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 65. Israel Prostate Cancer Therapeutics Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 66. Turkey Prostate Cancer Therapeutics Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 67. GCC Country Prostate Cancer Therapeutics Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 68. Manufacturing Cost Structure Analysis of Prostate Cancer Therapeutics Drugs in 2021

Figure 69. Manufacturing Process Analysis of Prostate Cancer Therapeutics Drugs

Figure 70. Industry Chain Structure of Prostate Cancer Therapeutics Drugs

Figure 71. Channels of Distribution

Figure 72. Distributors Profiles